Tempus Growth, Revenue, Number of Employees and Funding
Tempus's revenue is currently N/A per year.
Tempus received $110.0M in venture funding in August 2018.
Tempus is a technology company that is building the worldâ€™s largest library of molecular and clinical data and an operating system to make that data accessible and useful. We enable physicians to deliver personalized cancer care for patients through our interactive analytical and machine learning platform. We provide genomic sequencing services and analyze molecular and therapeutic data to empower physicians to make real-time, data-driven decisions. Our goal is for each patient to benefit from the treatment of others who came before by providing physicians with tools that learn as we gather more data. For more information, visit tempus.com and visit us on Facebook (Tempus Labs) and Twitter (@TempusLabs). For more information on Eric Lefkofsky, visit lefkofsky.com.keywords:N/A
Number of Employees
Employee Growth %
|2017-09-26||$70.0M||C||New Enterprise Associates||Article|
|2018-03-21||$80.0M||Undisclosed||T. Rowe Price||Article|
Tempus Executive Hires
|2017-04-06||Erik Phelps||VP General Counsel||Article|